Andrew Nash

Chief Executive Officer chez ZENYTH THERAPEUTICS LIMITED

Health Technology

Profil

Andrew Nash is currently the Chief Executive Officer & Director at CSL Innovation Pty Ltd.
He is also the Chief Scientific Officer, SVP & Head-Research at CSL Ltd.

Postes actifs de Andrew Nash

Sociétés	Poste	Début
ZENYTH THERAPEUTICS LIMITED	Chief Executive Officer	-
CSL LIMITED	Chief Tech/Sci/R&D Officer	01/11/2006

Tous les postes actifs de Andrew Nash

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Andrew Nash

Relations

Relations au 1er degré

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées	1
CSL LIMITED	Health Technology

Entreprise privées	1
CSL Innovation Pty Ltd. CSL Innovation Pty Ltd. Pharmaceuticals: MajorHealth Technology CSL Innovation Pty Ltd. develops pharmaceutical products. The firm also develops human antibody inhibitors of the granulocyte-macrophage colony stimulating factor receptor alpha subunit, GM-CSFRa, for potential therapeutic use in inflammatory diseases. The company was founded in 1986 and is headquartered in Richmond, Australia.	Health Technology